Mid cap
Akums FY26 call transcript adds nothing new after earlier disclosure
The full transcript of the Q4 FY26 call confirms results already known. No material surprise for the market.
Saregama sets 60-65% music margin target, skips Dhurandhar 2
In Q4 FY26 call, management reveals it walked away from a major acquisition amid peer pressure, while guiding margin expansion and a ₹300-350 cr content budget.
Embassy targets ₹6,000 cr pre-sales, plans to cut debt cost to 10%
The developer's FY27 roadmap includes 30% pre-sales growth and a refinancing plan to reduce cost of debt from 14.8% to 10% within 12-18 months.
Garware Technical Fibres posts marginal PAT dip in FY26 on ₹13.9 cr labour charge
Consolidated PAT falls to ₹198.68 cr from ₹231.54 cr; board recommends ₹1 final dividend on top of ₹8 interim.
Saatvik Green delays 4 GW plant, production pushed past Q1 FY27
A month after guiding March 2026 commissioning, the company now says module equipment move-in starts June — revenue from the plant slips out of the first quarter.
JSW Cement adds 2.5 MTPA capacity at Nagaur for ₹430 cr
Board also approved FY26 results showing PBT before exceptional items more than tripled to ₹843.54 cr, but a ₹1,466 cr exceptional charge on CCPS conversion weighed on net profit. Dividend of ₹0.50 per share recommended.
Sansera guides FY27 ADS revenue ₹550-600 cr, order backlog ₹44.6 bn
Aerospace & defence segment drives multi-year visibility; capex plan similar to FY26.
Inox India lands ₹322 cr in orders, enters space vertical with mega cryo deal
Order book surges 21% to ₹1,514 cr; space exploration customer orders large-scale cryogenic tanks.
Kwality Wall's posts ₹3,688 mn net loss; filing adds nothing new
Audited results confirm prior limited review numbers. Board also appointed Walker Chandiok & Co. as statutory auditors for five years, a routine step after listing.
ABFRL pumps ₹175 cr into Tasva, lifts stake to 89%
The capital infusion is routine—below materiality thresholds—and doesn't change the investment case for India's largest ethnic wear bet.
Amagi returns to profit but loses 30 small clients as margins shrink
Q4 FY26 revenue hit ₹1,506 cr, net profit ₹72 cr, but gross margins compressed from customer pricing renegotiations. Management flags strategic pivot to enterprise clients.
Viyash Scientific targets ₹1,000 cr EBITDA in 2-3 years, pivots to companion animals
Management's May concall reaffirms synergy-led margin expansion and sets an FY27 EBITDA run rate of ~₹800 crore.
Sansera confirms Q4 & FY26 results; all figures earlier disclosed
The earnings release matches previously reported numbers. No material new information for investors.
Sansera guides FY27 ADS at ₹5,500-6,000 Mn; order backlog 30% of m-cap
The auto component maker gave quantified revenue guidance for the first time, with an ADS order backlog worth ₹44,638 Mn — roughly 30% of its market cap — providing unusual forward visibility for a mid-cap.
Sansera Engineering closes FY26 with 50.7% profit surge
Consolidated net profit jumps to ₹327 cr on 16% revenue growth; board adds heavyweight directors and recommends ₹4 dividend
Sansera Engineering profit jumps 50.7% in FY26, board gets a revamp
Consolidated net profit surges to ₹327 crore, aided by lower finance costs. Board recommends ₹4/share final dividend and inducts three independent directors, including a former Renault India CEO.
Embassy eyes ₹6,000 Cr pre-sales in FY27 after record FY26
FY26 pre-sales up 128% to ₹4,631 Cr; company guides for 30% growth in FY27, backed by launches and ₹30,848 Cr embedded surplus.
Smartworks adds 4 lakh sqft in Gurugram for ₹60 cr
The expansion is 4% of operational capacity and 1.2% of market cap — incremental, not a strategic shift.
Strides Pharma's flagship plant draws 5 FDA observations
A Form 483 at the company's main manufacturing site raises the stakes for a warning letter or import ban. Response due in 15 days.
Consolidated profit up, standalone flat for Power Mech in FY26
Net profit at consolidated level rises to ₹411.68 crore from ₹347.55 crore; parent's standalone profit nearly unchanged at ₹298.37 crore.
MedPlus profit jumps 46% as pharmacy margins expand
Net profit hit ₹2.20 billion on 12% revenue growth for FY26. The board also shuffled its top ranks.
Whirlpool India's Q4 PBT falls 29% even as revenue picks up 9%
Full-year profitability also down, with regulatory headwinds and commodity inflation eating into margin gains.
MedPlus profit jumps 46% to ₹2,196.1 mn, revenue up 12% to ₹68,924.6 mn
Annual results show strong margin expansion; profit growth outpaces revenue by nearly 4x.
Saatvik Green Energy revenue jumps 111%, PAT rises 64% in FY26
FY26 revenue at ₹4,548 cr, PAT at ₹357 cr. Order book of 5.89 GW provides visibility, but PAT growth trails revenue growth, suggesting margin compression.
Saatvik Green's standalone profit plunged 60% as subsidiary drove group growth
Parent margins compressed by impairment and tech shift; consolidated revenue doubled but standalone net fell to ₹62 cr